PRTN3 and rheumatoid arthritis: Recent studies have demonstrated an upregulation of gene expression and activation of transcription factors within the IL-6/STAT3 pathway in anti-citrullinated peptide antibody (ACPA)-negative RA patients, in contrast to those who are ACPA-positive [12, 15, 16].